Last reviewed · How we verify
NCT03125759
The Association of Omentin and Ischemic Stroke
trial in Stroke in 2,000 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | Xi'an No.3 Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Conditions studied
- Stroke — all drugs for Stroke →
- Brain Ischemia — all drugs for Brain Ischemia →
- Adipokines — all drugs for Adipokines →
- Mutation — all drugs for Mutation →
Sponsor
Xi'an No.3 Hospital
Who can join
Eligibility, any sex, with Stroke or Brain Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study aims to research whether there is a relationship between omentin and ischemic stroke on the aspects of incidence, severity, and recovery etc.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03125759
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Xi'an No.3 Hospital trials
Trials by the same sponsor.
- NCT07139509 — Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma · Phase 1 · recruiting
- NCT06390761 — Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation · NA · recruiting
- NCT06001047 — Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV · NA · recruiting
- NCT05561088 — Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke · NA · recruiting
- NCT05424978 — Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03125759 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xi'an No.3 Hospital
- Last refreshed: 24 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03125759.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing